Mercado de medicamentos biotecnológicos en el Sistema General de Seguridad Social en Salud / Biotechnological drug market in the General Social Security System in Health
Cienc. tecnol. salud vis. ocul
; 10(2): 59-78, jul.-dec. 2012. ilus, tab
Article
in Spanish
| LILACS
| ID: lil-661953
Responsible library:
CO149.2
RESUMEN
En este artículo se revisa cómo es el mercado de los medicamentos biotecnológicos que presentan mayor recobro al Sistema General de Seguridad Social en Salud, según el perfil epidemiológico y demográfico de la población colombiana. De igual manera, se resalta la importancia de la competencia en la industria farmacéutica biotecnológica, al permitir mayor acceso a la población, al reducir los precios de estos productos y, consecuentemente, al favorecer las finanzas del sector salud.
ABSTRACT
This paper reviews the market of biotechnological drugs that show a higher collection to the General Social Security System in Health, according to the demographic and epidemiological profile of the Colombian population. It also highlights the importance of competition in the pharmaceutical biotechnology industry by granting greater access to the population,reducing the prices of these products and, consequently, favoring the health sector finances.
Full text:
Available
Collection:
International databases
Health context:
Sustainable Health Agenda for the Americas
Health problem:
Goal 5: Medicines, vaccines and health technologies
Database:
LILACS
Main subject:
Social Security
/
Biotechnology
/
Drug Industry
Aspects:
Social determinants of health
Limits:
Humans
Language:
Spanish
Journal:
Cienc. tecnol. salud vis. ocul
Journal subject:
Medical Informatics
/
Ophthalmology
/
Optometry
/
TECNOLOGIA
Year:
2012
Document type:
Article
Affiliation country:
Colombia
Institution/Affiliation country:
Universidad Colegio Mayor de Cundinamarca/CO
/
Universidad Jorge Tadeo Lozano/CO
